Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries G1 Therapeutics Inc (NQ: GTHX ) 7.150 UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 7.150 Bid (Size) 7.140 (212) Ask (Size) 7.180 (13) Prev. Close 7.150 Today's Range 7.150 - 7.150 52wk Range 1.080 - 7.190 Shares Outstanding 42,705,532 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer September 18, 2024 From G1 Therapeutics Via GlobeNewswire Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period September 05, 2024 From G1 Therapeutics Via GlobeNewswire Performance YTD +129.90% +129.90% 1 Month +0.85% +0.85% 3 Month +191.84% +191.84% 6 Month +55.43% +55.43% 1 Year +425.74% +425.74% More News Read More SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, PETQ, GTHX on Behalf of Shareholders August 15, 2024 From Halper Sadeh LLC Via GlobeNewswire Why Is G1 Therapeutics (GTHX) Stock Up 66% Today? August 07, 2024 Via InvestorPlace BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq – TWKS), PetIQ, Inc. (Nasdaq – PETQ), G1 Therapeutics, Inc. (Nasdaq – GTHX), GSE Solutions, Inc. (Nasdaq – GVP) August 15, 2024 From Brodsky & Smith LLC Via GlobeNewswire G1 THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of G1 Therapeutics, Inc. - GTHX August 09, 2024 From Kahn Swick & Foti, LLC Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders August 09, 2024 From Halper Sadeh LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thoughtworks Holding, Inc. (Nasdaq – TWKS), PetIQ, Inc. (Nasdaq – PETQ), G1 Therapeutics, Inc. (Nasdaq – GTHX), GSE Solutions, Inc. (Nasdaq – GVP) August 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights August 08, 2024 From G1 Therapeutics Via GlobeNewswire Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast August 07, 2024 Via Benzinga Topics Stocks Exposures US Equities Crude Oil Jumps Over 3%; Upstart Shares Spike Higher August 07, 2024 Via Benzinga Exposures Fossil Fuels Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates August 07, 2024 Via Benzinga Topics Earnings Exposures Financial GTHX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of G1 Therapeutics, Inc. Is Fair to Shareholders August 07, 2024 From Halper Sadeh LLC Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 07, 2024 Via InvestorPlace Pharmacosmos Group to Acquire G1 Therapeutics August 07, 2024 From G1 Therapeutics; Pharmacosmos Via GlobeNewswire G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 July 25, 2024 From G1 Therapeutics Via GlobeNewswire G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025 July 15, 2024 Via InvestorPlace Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble July 10, 2024 Via InvestorPlace Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday June 25, 2024 Via Benzinga Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears June 24, 2024 Via InvestorPlace Exposures Product Safety Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts June 24, 2024 Via InvestorPlace Topics Workforce Exposures Layoff Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge June 24, 2024 Via Benzinga Why Is Cancer-Focused G1 Therapeutics Stock Trading Lower On Monday? June 24, 2024 Via Benzinga Why Is G1 Therapeutics (GTHX) Stock Down 56% Today? June 24, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 24, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.